Protease-resistant prion protein produced in vitro lacks detectable infectivity.

References

1. Antoniou M. 1991; Induction of erythroid-specific expression in murine erythroleukaemia (MEL) cell lines. In Methods in Molecular Biology vol 7 Gene Transfer and Expression Protocols 1st edn, pp 421–433 Edited by Murray E. J. Clifton. NJ: Humana Press;
   [Google Scholar]
2. Bessen R. A., Kocisko D. A., Raymond G. J., Nandan S., Lansbury P. T., Caughey B. 1995; Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375:698–700
   [Google Scholar]
3. Bueler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., Weissmann C. 1993; Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347
   [Google Scholar]
4. Caughey B., Raymond G. J., Kocisko D. A., Lansbury P. T. Jr 1997; Scrapie infectivity correlates with converting activity, protease resistance, and aggregation of scrapie-associated prion protein in guanidine denaturation studies. Journal of Virology 71:4107–4110
   [Google Scholar]
5. Collinge J., Palmer M. S., Sidle K. C. L., Gowland I., Medori R., Ironside J., Lantos P. L. 1995; Transmission of fatal familial insomnia to laboratory animals. Lancet 346:569–570
   [Google Scholar]
6. Collinge J., Sidle K. C. L., Meads J., Ironside J., Hill A. F. 1996; Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383:685–690
   [Google Scholar]
7. Hsiao K. K., Groth D., Scott M., Yang S.-L., Serban H., Rapp D., Foster D., Torchia M., DeArmond S. J., Prusiner S. B. 1994; Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proceedings of the National Academy of Sciences, USA 91:9126–9130
   [Google Scholar]
8. Hsiao K. K., Scott M., Foster D., Groth D. F., DeArmond S. J., Prusiner S. B. 1990; Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science 250:1587–1590
   [Google Scholar]
9. Kascsak R. J., Rubenstein R., Merz P. A., Tonna DeMasi M., Fersko R., Carp R. I., Wisniewski H. M., Diringer H. 1987; Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. Journal of Virology 61:3688–3693
   [Google Scholar]
10. Kocisko D. A., Come J. H., Priola S. A., Chesebro B., Raymond G. J., Lansbury P. T., Caughey B. 1994; Cell-free formation of protease-resistant prion protein. Nature 370:471–474
    [Google Scholar]
11. Kocisko D. A., Priola S. A., Raymond G. J., Chesebro B., Lansbury P. T. Jr, Caughey B. 1995; Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier. Proceedings of the National Academy of Sciences, USA 92:3923–3927
    [Google Scholar]
12. Lasmezas C. I., Deslys J.-P., Robain O., Jaegly A., Beringue V., Peyrin J.-M., Fournier J.-G., Hauw J.-J., Rossier J., Dormont D. 1997; Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275:402–405
    [Google Scholar]
13. Needham M., Egerton M., Millest A., Evans S., Popplewell M., Cerillo G., McPheat J., Monk A., Jack A., Johnstone D. and others 1995; Further development of the locus control region/murine erythroleukemia expression system: high level expression and characterization of recombinant human calcitonin receptor. Protein Expression and Purification 6:124–131
    [Google Scholar]
14. Pan K.-M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R. J., Cohen F. E., Prusiner S. B. 1993; Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proceedings of the National Academy of Sciences, USA 90:10962–10966
    [Google Scholar]
15. Prusiner S. B. 1987; Bioassays of prions. In Prions: Novel Infectious Pathogens causing Scrapie and Creutzfeldt–Jakob Disease pp 65–81 Edited by Prusiner S. B., McKinley M. P. San Diego: Academic Press;
    [Google Scholar]
16. Prusiner S. B. 1991; Molecular biology of prion diseases. Science 252:1515–1522
    [Google Scholar]
17. Prusiner S. B., Bolton D. C., Groth D. F., Bowman K., Cochran S. P., McKinley M. P. 1982; Further purification and characterization of scrapie prions. Biochemistry 21:6942–6950
    [Google Scholar]
18. Scott M., Foster D., Mirenda C., Serban D., Coufal F., Walchli M., Torchia M., Groth D., Carlson G., DeArmond S. J., Westaway D., Prusiner S. B. 1989; Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59:847–857
    [Google Scholar]
19. Scott M. R., Kohler R., Foster D., Prusiner S. B. 1992; Chimeric prion protein expression in cultured cells and transgenic mice. Protein Science 1:986–997
    [Google Scholar]
20. Scott M., Groth D., Foster D., Torchia M., Yang S. L., DeArmond S. J., Prusiner S. B. 1993; Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73:979–988
    [Google Scholar]
21. Telling G. C., Parchi P., DeArmond S. J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S. B. 1996; Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079–2082
    [Google Scholar]
22. Weissmann C. 1991; Spongiform encephalopathies. The prion′s progress. Nature 349:569–571
    [Google Scholar]
23. Xi Y. G., Ingrosso L., Ladogana A., Masullo C., Pocchiari M. 1992; Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature 356:598–601
    [Google Scholar]